Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
LVCLY
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Relative Strength
LVCLY
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Earnings Growth
YoY
Current
Estimates
Q3.21
N/A
NA
vs NA
Q4.21
N/A
-0.00
vs -0.00
Q1.22
N/A
NA
vs NA
Q2.22
N/A
-0.00
vs -0.00
Q3.22
N/A
NA
vs NA
Q4.22
N/A
-0.00
vs -0.00
Q1.23
N/A
NA
vs NA
Q2.23
N/A
-0.00
vs -0.00
Q3.23
N/A
NA
vs NA
Q4.23
N/A
-0.00
vs -0.00
Sales Growth
YoY
Current
Estimates
Q3.21
NA
NA vs NA
Q4.21
-100%
NA vs 112.8K
Q1.22
NA
NA vs NA
Q2.22
-98%
3.4K vs 155.4K
Q3.22
NA
NA vs NA
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
+1134%
42K vs 3.4K
Q3.23
NA
NA vs NA
Q4.23
NA
NA vs NA
Return on Equity
QoQ
Q1.22
NA
NA
vs NA
Q2.22
-30%
-0.30
vs -0.18
Q3.22
NA
NA
vs NA
Q4.22
-48%
-0.48
vs -0.30
Q1.23
NA
NA
vs NA
Q2.23
-20%
-0.20
vs -0.48
Q3.23
NA
NA
vs NA
Q4.23
-40%
-0.40
vs -0.20
Q1.24
NA
NA
vs NA
Q2.24
-21%
-0.21
vs -0.40
Institutionnal Ownership
N/A
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Q4.25
NA
NA
vs NA
NA
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
OTC
Unprofitable
Unprofitable
0.01Â ( 24.39%)
Relative Strenght
Volume Buzz
-73%
Earning Acce
No
Dist 52w H.
62%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How LVCLY compares to sector?